Jyoti Resins Q2 FY27: revenue +31% YoY, margin compression caps PAT growth at 8%
PAT +7.69% YoY · revenue +31.31% · margins compressing
₹97.67 Cr
+31.31% YoY
₹18.48 Cr
+7.69% YoY
18.38%
-3.8pp YoY
₹15
Jyoti Resins' standalone revenue grew 31.3% YoY to ₹97.67 Cr (from ₹74.38 Cr in Q2 FY26), but net profit rose only 7.7% YoY to ₹18.48 Cr (from ₹17.16 Cr), as margins compressed: OPM fell to 23.04% from 27.52% a year ago, and NPM to 18.38% from 22.13%. The squeeze traces mainly to raw-material cost — cost of materials consumed plus the change in inventories (the two lines together approximate the true input-cost run-rate) rose to ₹36.20 Cr from ₹20.28 Cr a year ago, a 78.5% jump that outpaced revenue growth by a wide margin. Sequentially the picture improved — PAT is up 57.3% QoQ and OPM/NPM both expanded sharply from Q1 FY27's trough (OPM 14.43%→23.04%, NPM 12.92%→18.38%) — but that recovery is off a weak base: Q1 FY27 itself had posted a 32% YoY PAT decline, so this quarter's sequential bounce is a partial recovery rather than fresh strength, and YoY remains the harder read — profit growth trailing revenue growth by roughly 24 points is the real story.
Q2 FY-2027 vs prior quarters
No street/consensus estimates for this micro-cap turned up in a search, so vsStreet is unknown; no management press release accompanied this filing beyond the regulatory board-outcome letter, so there is no fresh management commentary to reconcile against the numbers. Against the FY29 targets laid out in the August 2026 concall (₹500 Cr revenue, 23-25% EBITDA margin, 15-20% volume growth, a new 3,500-tonne/month line targeted for Q2 FY27, and normalizing 120-day receivables within two quarters), this quarter's OPM of 23.04% sits at the low end of the margin band — on-track but not yet comfortably inside it — while the filing gives no update on the new capacity's commissioning status. Trade receivables stood at ₹161.66 Cr at September 30, 2026, up 25.6% YoY from ₹128.70 Cr, with no sign yet of the stated normalization; the two-quarter window set in August points to Q3 FY27 as the checkpoint. Separately, the company secured NSE listing approval on October 7, 2026, a liquidity/visibility milestone unrelated to this quarter's operating numbers.
The stock went into the print at ₹884.9, up 4.4% over the past month of trading.
For context: this is the second-highest quarterly PAT of the last 6 quarters; revenue is at a 6-quarter high.
What the summary numbers don't show
EPS ₹15 (basic) vs ₹14 a year ago and ₹10 last quarter
FY29 revenue target ₹500 Cr with 23-25% EBITDA; 15-20% volume growth; New 3,500-tonne/month capacity (₹600-650 Cr revenue potential) ready Q2 FY27; Aim to normalize 120-day receivables within 2 quarters.
W1
Receivables normalization checkpoint: management targeted normalizing 120-day receivables within 2 quarters of the Aug 2026 concall; receivables at ₹161.66 Cr show no improvement yet — Q3 FY27 is the stated deadline
W2
New 3,500-tonne/month capacity (₹600-650 Cr revenue potential cited) was targeted for Q2 FY27; this filing gives no commissioning update — confirm status next quarter
W3
OPM at 23.04% sits at the low end of management's 23-25% FY29 EBITDA band — watch whether the QoQ margin recovery (14.43%→23.04%) continues or raw-material costs push it back down
Only standalone statement filed (no consolidated section); no exceptional items either period; other income includes an immaterial ₹59.16 lakh reversal of excess earlier-years depreciation (Ind AS 8 note); all figures converted from ₹ Lakh to ₹ Crore.
Revenue surge masks PAT deceleration; capacity live but DSO unresolved
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Met capacity milestone and broadly affirmed FY29 ₹500 Cr target; DSO normalization goal pushed out from 2 quarters to 1–2 quarters.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Jyoti delivered a strong 31% revenue beat and completed its 3,500-tonne capacity expansion on time. However, PAT growth of only 7.8% YoY lags sharply, signaling margin compression under VAM cost pressure. Management is maintaining its ₹500 Cr FY29 guidance with 23–25% EBITDA, but elevated working capital (DSO 140–160 days vs 120-day target) remains a drag. Multi-year opportunity is clear; near-term execution shows friction.
₹97.7 Cr
Revenue · +31.3% YoY₹18.5 Cr
Reported PAT · +7.8% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Achieved ~15% volume growth in Q2
MET31.3% YoY revenue growth; volume contribution unclear, likely driven by price increases + volume
EBITDA margins recovered to 23% in Q2 from 14.4% in Q1
METOPM 23.0% delivered, consistent with EBITDA claim
Capacity expansion to 3,500 tonnes/month complete; can support ₹600–700 Cr revenue
METExpansion confirmed; currently at 70–75% utilization; run-rate potential ~₹670 Cr is reasonable
Gross margins ~63–64%, EBITDA 23% in Q2, targeting 24–25% in H2
PartialOPM 23% delivered matches claim; NPM only 18.4%, suggesting SG&A or other costs are high; H2 guidance not yet tested
DSO normalizing towards 120 days within 1–2 quarters from now
MISSDSO still 140–160 days in newer markets, 75–100 in mature; management delayed goal, not achieved in prior quarter
PAT YoY growth reflects full-year benefit; margin intact despite VAM costs
OVERSTATEDPAT grew 7.8% YoY despite 31.3% revenue growth; margin pressure evident; claim overstated
Earnings quality
What changed since the last call
Capacity milestone achieved
Upgrade3,500-tonne brownfield expansion completed Q2 (on schedule). Provides ₹600–700 Cr revenue headroom; prior call targeted Q2 delivery.
Dealer base and state expansion accelerated
Upgrade14,000 dealers (from 10,000 baseline); expanded to 16 states (added Odisha). 2,500 carpenter meets in H1 (vs 30 last year Q1). Signals distribution moat building.
DSO normalization goal extended
DowngradePrior 2-quarter normalization goal not achieved; still 140–160 days (vs 120-day prior target). Now expected in 1–2 quarters, with strategic justification (new markets = high credit terms).
Margin pressure acknowledged but guided sustained
NeutralVAM cost volatility cited (₹75–80/kg historical, peaked ₹200/kg March, now ₹115/kg); management expects 24–25% EBITDA in H2 despite headwinds. OPM at 23% this quarter (lower bound).
OEM segment targeting accelerated
UpgradeCurrently ~6% of revenue; targeting 10–15% long-term. New teams onboarded in Telangana, Mumbai, Jaipur, Indore, Surat, Ahmedabad. Contracts quarterly/yearly, not exclusive.
The Q&A
Analysts pressed hard on VAM cost hedging and margin trajectories (Rahul Jain, Mahak Singhvi). Management held 24–25% EBITDA guidance but acknowledged 2–3% band volatility. Defensive on working capital rationale; Harsh Chaurasia probed maturity vs newmarket credit terms—management argued strategic necessity to maintain dealer relationships.
FY29 ₹500 Cr achievability — Rahul Jain, ICICI Securities
AnsweredYes, optimistic on Q3–Q4. Close to ₹375–₹400 Cr this year, then scale towards ₹500 Cr FY29. Targeting 15–17% volume growth annually; price increases accepted by market after VAM stabilization.
EBITDA margin outlook — Rahul Jain, ICICI Securities
PartialYes, doable. VAM procurement fixed for 90 days at ₹100–115/kg helps. Marketing spend 7% of revenue (vs prior 3.5–6%). Gross margins 63–64% sustainable. 22–25% EBITDA range maintained; not concerned about 2–3% band.
Working capital and receivables — Rahul Jain, ICICI Securities
PartialStarting channel financing; aiming to normalize to 120 days within 1–2 quarters. Newer markets need higher credit terms for relationship building; mature markets stay 75–100 days. Debt-free company, so can absorb stretch.
VAM pricing and hedging — Mahak Singhvi, Bank of Baroda
AnsweredVAM now ₹115/kg. Procurement locked for 90 days at ₹100 level; helped Q2 margin. 15% appreciation from March to October offset by price increases (6–7% taken in May). Crude and geopolitics matter; monitoring closely.
Capacity utilization and growth headroom — Mahak Singhvi, Bank of Baroda
AnsweredNo immediate capex needed. 3,500-tonne plant can support ₹600–700 Cr revenue. Capex done; now focus on marketing and distribution to penetrate deeper. Next expansion (Gujarat greenfield, 1,500 tonnes/month, ₹45–50 Cr) is strategic but not imminent; market conditions will decide timing.
Geographic growth and new market credits — Mishka, (analyst)
AnsweredBoth. Expanded to 16 states (added Odisha). Deeper penetration in Karnataka (targeting 25% of revenue), existing states. New geographies have lower repeat orders; aiming for 50% repeat within 1 year, 75% longer-term. OEM segment new, targeting 10–15% revenue in future.
OEM strategy and long-term mix — Mishka, (analyst)
PartialNo exclusivity; volume contracts (yearly/quarterly). Targeting 10–15% revenue long-term, but not this year—too early. Onboarding teams in 4 metro cities. Focus is on core wood adhesives carpenter base first; OEM is ancillary growth path.
Brand perception vs low-cost competitors — Digvijay Ghorpade, Q&A window
AnsweredHighest Facebook followers (>2M), strong Instagram growth (65K followers). Maintaining quality standards; OEM grades are lower-cost but not quality-compromised. Focus on carpenter community engagement (2,500 meets in H1) and associations with Pankaj Tripathi for brand equity.
Digital marketing and influencer strategy — Moderator, Q&A window
Answered2M+ Facebook followers; 65K Instagram followers (from 7K previously). Ramp-up in influencer community. Mirzapur movie tie-in: 9,200 screens in Mumbai for ad placement. Quarterly escalation of digital spend; carpenter meets (5x vs prior year).
FY27 full-year revenue guidance — Rahul Jain, ICICI Securities
PartialClose to ₹375–₹400 Cr full-year. Q3–Q4 are fruitful seasons (festive demand). Confident on reaching upper end of that range. VAM cost benefit and geographical expansion supporting growth.
Mature vs new market margin differential — Harsh Chaurasia, equity analyst
AnsweredMature markets: 75–100 days DSO, standard terms. New markets: 120–150 days DSO, higher credits for dealer relationship. Margins converge as territory matures; repeat business kicks in within 2–3 years.
Guidance
FY27 full-year target ₹375–₹400 Cr (vs ₹380 Cr earlier; slightly reiterated range)
MediumQ2 ₹97.7 Cr reported. Q3–Q4 are 'fruitful' festive seasons; management expects strong finish. VAM cost benefit and capex-completion momentum supporting.
FY29 target ₹500 Cr (reaffirmed)
HighBacked by completed 3,500-tonne capacity (capable of ₹600–700 Cr at full utilization), 14,000-dealer base, and 16-state footprint. Volume growth 15–20% CAGR; price support from market acceptance.
Longer-term aspiration: ₹1,000 Cr (mentioned but not quantified timeline)
LowNo specific capex plan or timeline; management frames as multi-year journey. Contingent on sustained dealer growth and OEM ramp.
EBITDA 23–25% range (FY27–FY28 outlook)
MediumQ2 delivered 23% (lower bound). H2 FY27 expected 24–25% (not yet achieved). Management cites VAM cost stabilization and fixed procurement contracts as support; notes 2–3% volatility band.
Gross margin target ~65% (management commentary suggests 63–64% baseline, targeting 65%+)
MediumCurrently maintained at 63–64%. Further VAM cost declines could lift gross margin; then operating leverage as SG&A normalizes post-expansion.
SG&A reduction as revenue scales (from current 7% towards long-term 3–4%)
MediumCurrently 7% due to 150-person hiring, carpenter meets (2,500 in H1), influencer campaigns, and brand building. Revert as percentage of sales once growth momentum sustains.
No immediate capex. Brownfield expansion complete; next phase (Gujarat greenfield, 1,500 tonnes/month, ₹45–50 Cr estimated) contingent on market conditions
HighCurrent 3,500-tonne capacity at 70–75% utilization provides 18–24 months runway. Gujarat facility is strategic but not imminent; management will assess demand trajectory.
Risks the call surfaced
Raw material cost inflation
HighVAM historically ₹75–80/kg, spiked to ₹200/kg in March, now ₹115/kg. Crude price and geopolitics (Middle East) drive. If crude re-spikes, VAM could exceed ₹150/kg, compressing margins below 23% target.
Working capital deterioration
MediumDSO 140–160 days in newer markets vs ₹120-day prior target. Newer geographies (15% revenue) require extended credit terms to build dealer relationships. Net impact: ~₹15–20 Cr working capital headwind vs normalized levels. Strategic choice but drains cash.
Margin compression YoY
MediumPAT grew 7.8% YoY on 31.3% revenue growth, indicating gross margin stability (63–64%) but SG&A dilution. SG&A now 7% of revenue (vs historical 3.5–6%) due to 150 new hires, carpenter meets (2,500 in H1), and brand spend. If this spend doesn't productively scale into revenue, it drags profitability.
Demand seasonality and macro exposure
MediumAdhesive demand is a proxy for residential construction. Q1–Q2 softer (real estate absorption slow, rainy season). Q3–Q4 (festive, construction season) critical to annual guidance. FY27 full-year target ₹375–₹400 Cr depends entirely on Q3–Q4 delivery. Macro slowdown or NPA stress could weigh.
Competitive pricing pressure
MediumAnalyst (Digvijay Ghorpade) noted regional brands selling cheaper, lower-quality products perceived as 'warranty-backed white glue'. Euro's premium positioning must be defended through brand spend and quality consistency. If brand spend is ineffective or competitors match quality, pricing power erodes.
Management
Score 7/10. Clear on strategic narrative (₹500 Cr FY29, ₹1,000 Cr aspiration). Direct on numbers where comfortable (capacity, dealer base, margins). Defensive on working capital rationale, offering strategic justification rather than aggressive timeline. Met capacity milestone (3,500 tonnes by Q2 as promised). Margin recovery (14.4% to 23%) on schedule. Dealer expansion (10K to 14K) and state addition (15 to 16) on track. DSO normalization goal pushed (2 quarters → 1–2 quarters); not yet achieved.
1 · Q3 & Q4 FY27
Festive season demand spike (Diwali effect); carpenter and dealer engagement peak
2 · Q4 FY27
DSO normalization to 120 days (management target for next 1–2 quarters)
3 · H2 FY27
EBITDA margins recover to 24–25% range as VAM costs stabilize
Multi-year opportunity is clear; near-term execution shows friction.